Nikhil Prasad Fact checked by:Thailand Medical News Team Apr 07, 2026 2 hours, 12 minutes ago
Medical News: A new large-scale safety analysis is raising fresh concerns about two widely used hair loss and prostate drugs - finasteride and dutasteride - after researchers found growing signals linking them to depression, anxiety, and even suicidal thoughts. The findings, based on global real-world data, suggest that while both medications carry risks, finasteride may pose a significantly higher concern, especially among younger men.
Study reveals popular hair loss drugs may trigger serious mental health risks in some users
What These Drugs Do and Why They Matter
Finasteride and dutasteride belong to a class of medications known as 5-alpha reductase inhibitors. They work by lowering levels of dihydrotestosterone, a hormone responsible for hair loss and prostate enlargement. While effective, these drugs have long been associated with sexual side effects. Now, mounting evidence suggests the impact may extend far beyond physical symptoms.
Alarming Rise in Psychiatric Reports
The research analyzed thousands of adverse event reports from the U.S. FDA’s global safety database. According to the data, more than 4,100 cases linked to finasteride were reviewed, compared to just over 200 for dutasteride. Depression-related issues were the most commonly reported, followed by problems with libido, anxiety, and suicidality.
Notably, men aged between 19 and 64 accounted for the majority of cases. Over time, reports of psychiatric side effects have steadily increased, with the highest numbers recorded between 2020 and 2025. Many cases were classified as serious, with outcomes described as “disabling,” highlighting the significant toll on daily life.
Finasteride Shows Stronger Risk Signals
A deeper statistical comparison revealed that finasteride had consistently higher associations with psychiatric issues compared to dutasteride. Reports of depression were more than three times as likely, while anxiety and suicidal tendencies also showed significantly elevated signals.
These findings are particularly concerning for younger men using finasteride for hair loss rather than medical prostate conditions. Experts believe this group may be more vulnerable due to psychological factors such as body image concerns and sensitivity to sexual side effects.
What Could Be Causing These Effects
Scientists suggest several biological explanations. One leading theory involves the disruption of neurosteroids - brain chemicals that help regulate mood and stress. By blocking hormone pathways, these drugs may reduce levels of allopregnanolone, a compound known for its calming and antidepressant effects.
Additionally, changes in hormone balance may interfere with brain signaling, including dopamine pathways linked to motivation and pleasure. Some studies also point to reduced brain cell growth in areas responsible for mood regulation.
Experts Urge Careful Screening and Monitoring
This
ont-size:16px">Medical News report highlights the growing call for doctors to conduct thorough mental health screenings before prescribing these medications. Researchers recommend evaluating patients for prior depression, anxiety, or suicidal thoughts, as well as monitoring mood changes closely after treatment begins.
Institutions involved in the study include UniCamillus University in Rome, University of Hertfordshire in the United Kingdom, Swansea University in Wales, “G. D’Annunzio” University in Italy, the Royal College of Psychiatrists in London, ASST Sette Laghi–Circolo e Fondazione Macchi Hospital in Italy, and Università degli Studi dell’Insubria in Italy.
Key Warning Signs Patients Should Watch For
Patients taking these medications are advised to seek medical help if they experience persistent sadness, loss of interest in daily activities, anxiety, sleep disturbances, or any thoughts of self-harm. Early intervention could be critical in preventing more severe outcomes.
Limitations But Strong Signals
While the study cannot prove direct causation due to the nature of voluntary reporting systems, the consistency and scale of the findings raise serious concerns. Underreporting and missing data remain challenges, but the trends are difficult to ignore.
Conclusion
The growing body of evidence suggests that finasteride, and to a lesser extent dutasteride, may be linked to significant mental health risks in some individuals. The combination of hormonal disruption, brain chemistry changes, and psychological stressors appears to create a complex risk profile, particularly in younger users. Greater awareness, careful patient selection, and ongoing monitoring are essential to minimize harm. While these medications remain effective for their intended uses, both doctors and patients must weigh the benefits against the potential for serious psychiatric side effects, especially when used long-term.
The study findings were published in the peer reviewed journal: Brain Sciences.
https://www.mdpi.com/2076-3425/16/4/394
For the latest on drugs that trigger mental health issues, keep on logging to Thailand
Medical News.
Read Also:
https://www.thailandmedical.news/articles/med-news
https://www.thailandmedical.news/articles/mental-health
Share
Tweet
Share
